Making a Dent in the Trillion-Dollar Problem: Toward Zero Defects
Peter J. Pronovost(University Hospitals of Cleveland), Amol S. Navathe(University of Pennsylvania), Mark E. Schario, Justin J. Coran(University Hospitals of Cleveland), Patrick Runnels(University School), George Topalsky, Eric Beck(University Hospitals of Cleveland), Sandeep Palakodeti, Todd M. Zeiger, Abirammy Sundaramoorthy(Clinical Innovations (United States)), Jonathan C. Sague(Case Western Reserve University), James M. Muisyo(University Hospitals of Cleveland), John W. Urwin(Beth Israel Deaconess Medical Center), Andrew Wilhelm(University Hospitals of Cleveland), Susan M. Shea(University of Pittsburgh)
Cited by 24
Related Papers
Transforming Healthcare Cybersecurity from Reactive to Proactive: Current Status and Future Recommendations
|Journal of Medical Systems|2020|136
The use of low‐titer group O whole blood is independently associated with improved survival compared to component therapy in adults with severe traumatic hemorrhage
|Transfusion|2020|124
Effect of leukoreduction and pathogen reduction on the hemostatic function of whole blood
|Transfusion|2019|43
The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Randomized, Double-Blind, Placebo-Controlled, Single-Center Trial
|Frontiers in Immunology|2020|42
Doing more with less: low-titer group O whole blood resulted in less total transfusions and an independent association with survival in adults with severe traumatic hemorrhage
|Journal of Thrombosis and Haemostasis|2023|42